Search Results 1651-1660 of 19530 for Hemoglobin

  1. Novel HSF1 Pathway Inhibitor NXP800 In Patients with Advanced Cholangiocarcinoma - Mayo Clinic

    * Hemoglobin ≥ 9.0 g/dL (obtained ≤ 14 days prior to registration) * Absolute neutrophil count (ANC) ≥ 1500/mm\^3 (obtained ≤ 14 days prior to ...

  2. A Phase 1 Study Of The Safety And Tolerability Of MT-125 In GBM Patients - Mayo Clinic

    Hemoglobin ≥9.0 g/dL 2. Absolute neutrophil count (ANC) ≥1500/mm3 3. Platelet count ≥100,000/mm3 4. Total bilirubin ≤1.5 x upper limit of normal (ULN) 5 ...

  3. PR3-AAV Resilient Remission or PRRR - Mayo Clinic

    ... hemoglobin < 7 gm/dl or platelet count < 100,000/?l - Aspartate aminotransferase or alanine aminotransferase or amylase > 2.5 times the upper limit of ...

  4. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (obtained within 21 days prior to registration);; Total bilirubin ≤ 1.5 times institutional upper limit of normal (ULN) (obtained ...

  5. Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    Hemoglobin ≥9.0 g/dL. Total bilirubin ≤1 x ULN; or total bilirubin ≤3.0 x ULN with direct bilirubin ≤1.5 x ULN in patients with well-documented ...

  6. Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression - Mayo Clinic

    hemoglobin greater than or equal to 9 g/dl;; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than 3 times the upper limit of normal ...

  7. A Safety to Evaluate the Safety and Effectiveness of Pressurized Intraperitoneal Aerosolized Chemotherapy in Ovarian, Uterine, Colorectal, and Gastric Cancer Patients - Mayo Clinic

    Hemoglobin >= 9 g/dl; Serum total bilirubin =< 1.5 x upper limit of normal (ULN); Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) ...

  8. Transfusion Medicine - Laboratory Medicine and Pathology - Mayo Clinic

    Coagulation and hemoglobin testing are performed in the operating rooms in order to provide guidance of anticoagulation and transfusion therapies.

  9. Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL or ≥ 5.6 mmol/L without transfusion or EPO dependency (within 7 days of assessment). Renal. Serum creatinine OR Measured or calculated ...

  10. What Complications Can Come From a Rib Fracture? - Mayo Clinic News Network

    Rib fractures are one of the most common bone breaks in older adults. While there's no direct treatment for fractured ribs that remain in alignment, medical ...